Kent is a Senior Vice President of Strategy and leads Merkle’s Global Health Strategy practice. He has been consulting in the areas of pharmaceutical, provider, and payer strategy for more than 20 years. In addition to broad blog/whitepaper and conference activity, he is published extensively in a variety of journals including, Research in Social and Administrative Pharmacy, Formulary, the Journal of Clinical Pharmacy and Therapeutics, and the Journal of Database Marketing.
Kent has worked with a number of clients in the pharmaceutical, healthcare, and animal health vertical including AbbVie, AstraZeneca, BMS, Boehringer Ingelheim, Novartis, Sanofi (Genzyme, Chattem and Merial), OHSU, Emblem Health, and Anthem, focusing on engagement, communication, and CRM strategy in the US, Canada, Europe, and Australasia. He has a Ph.D. in pharmaceutical strategy and policy from Dalhousie University in Halifax, NS, and holds the position of Assistant Professor, Clinical Pharmacy, at the James L. Winkle College of Pharmacy, University of Cincinnati.
Kent's Articles, Blog Posts, Webinars and More
What Does the Future Hold for Peer Reviewed Medicine?
Would you prescribe a drug just because other doctors “like” it? There are indications that this may already be happening, and health marketers should start thinking about what that means for them.
Topics:
Health
How Would You Rate Your Communications to HCPs?
It is critical to move away from an ad hoc approach incorporating email into your campaign strategy, and to take a more analytic approach to the frequency, content, cadence, and targeting of your overall email communication.
Topics:
CVS Health and Aetna will Redefine the Healthcare Experience for Consumers
What can CVS Health patients, Aetna members and marketers expect as a result of the proposed merger, and what's on the horizon beyond this momentous deal?
Have You Thought About the Pharma Rep as the Orchestrator of the HCP Relationship?
With the role of the pharma rep in decline, it’s critical for pharma companies to reinvent that role, especially as the industry shifts toward a people-based marketing framework that’s rooted in customer centricity. Integral to this shift is the concept of the rep as a franchisee.
Topics:
Health
The New Role of the Pharma Rep and Raising the Digital Stakes
Given the rapidly evolving changes to our healthcare system, as well as the overwhelming volume of content that healthcare professionals (HCP) are faced with daily across channels, a defined HCP communication strategy at the therapeutic and brand level is more important than ever for the pharmaceutical indust
Topics:
Health
Pharmaceutical Marketing: Are We Making a Difference?
A paycheck is nice, but the opportunity presented by pharmaceutical marketing means being able to change or even save someone's life through your work.
Topics:
Health
Non-Personal Promotion Is Ready to Take the Spotlight
Like the substitution for the star forward, or the lead actor in a Broadway hit, non-personal promotion (NPP) is ready to take center stage in targeted physician communications. Physicians, like consumers, have an evoked set of brands to which they refer in most situations.
Topics:
Health
2016 Is Around the Corner, Are There Gaps in Your Target Audience Strategy?
With access to physicians continuing to shrink, and pressure mounting for physicians themselves (and their associated clinics) to reduce costs and increase efficiency, it is time to really expand our focus to include one of the fastest-growing groups of professionals in the clinical space, namely nurse practi
Topics:
Health
The 4 Ps of Marketing
Many years ago, as a marketing professor teaching Introductory Marketing to the open minds of first and second-year business and commerce students, my task at hand was fairly straightforward.
Topics:
Health
Customer Experiences Continue to Be the Focal Point for 2015
For years, industries have been shifting their focus toward customer centricity, building business and deliverables around the customer, and truly creating a 360-degree view of our most important asset.
Topics:
Health
